Sid Subramony

Sid Subramony, Ph.D., joined Boxer Capital LLC in 2018. As Vice President, Dr. Subramony is responsible for conducting due diligence of public and private investments in healthcare. In his role, he also serves as a Member of the Board Directors for Tyra Biosciences.

Prior to joining Boxer, Dr. Subramony was a Vice President at H.I.G. Capital where he was a member of the investment team for the firm’s dedicated healthcare fund, evaluating public and private investment opportunities in the life sciences and representing H.I.G. on the board of Leiters Pharmacy. Prior to joining H.I.G., Dr. Subramony was a management consultant at the Boston Consulting Group (BCG) and served as a member of the firm’s healthcare practice.

Dr. Subramony received a Ph.D. in Biomedical Engineering from Columbia University as an NSF Graduate Research Fellow, an M.B.A. from Harvard Business School, and a Bachelor of Science in Biomedical Engineering and Economics, summa cum laude, from Rensselaer Polytechnic Institute. He has authored several scientific publications and is a co-inventor on multiple patents.